Medicare Enrolled
Dr. Lee Kubersky, MD
Neurology · Meadowbrook, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kubersky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kubersky?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kubersky
Dr. Lee Kubersky is a neurology specialist in Meadowbrook, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kubersky performed 9,815 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kubersky received a total of $61,224 from 82 pharmaceutical and/or device companies across 823 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kubersky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 4% volume in PA
$61,224 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗9,815
Medicare services
Top 4% in PA for neurology
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
9,000 | $5 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
391 | $80 | $275 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
168 | $116 | $350 |
| New patient office visit, complex (60-74 min) | 98 | $144 | $425 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
56 | $114 | $350 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 43 | $38 | $97 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
34 | $140 | $793 |
| Brain stimulator programming, first 15 minutes Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes. |
25 | $39 | $140 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$61,224
Total received (2018-2024)
Avg $8,746/year across 7 years
Top 9% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
82
Companies
823
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,885
2023
$5,842
2022
$14,700
2021
$27,243
2020
$1,762
2019
$3,628
2018
$6,164
Payments by company (2024)
ABBVIE INC.
$328
Boston Scientific Corporation
$196
ACADIA Pharmaceuticals Inc
$166
Abbott Laboratories
$145
SK Life Science, Inc.
$138
HARMONY BIOSCIENCES LLC
$128
E.R. Squibb & Sons, L.L.C.
$125
Amneal Pharmaceuticals LLC
$116
EMD Serono, Inc.
$114
Teva Pharmaceuticals USA, Inc.
$75
Novartis Pharmaceuticals Corporation
$65
PFIZER INC.
$64
Acorda Therapeutics, Inc
$39
Lilly USA, LLC
$39
UCB, Inc.
$36
Eisai Inc.
$26
CATALYST PHARMACEUTICALS, INC.
$23
Azurity Pharmaceuticals, Inc.
$17
Sumitomo Pharma America, Inc.
$16
REVANCE THERAPEUTICS, INC.
$15
Neurocrine Biosciences, Inc.
$14
Top 3 companies account for 36.6% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$22,241
ABBVIE INC.
$15,929
US WorldMeds, LLC
$4,023
UCB, Inc.
$2,714
Allergan, Inc.
$1,814
MDD US Operations, LLC
$1,645
Biogen, Inc.
$1,282
Abbott Laboratories
$964
GENZYME CORPORATION
$751
Teva Pharmaceuticals USA, Inc.
$647
Novartis Pharmaceuticals Corporation
$569
EMD Serono, Inc.
$518
Acorda Therapeutics, Inc
$468
Medtronic USA, Inc.
$465
ACADIA Pharmaceuticals Inc
$464
Amneal Pharmaceuticals LLC
$395
Lundbeck LLC
$344
Adamas Pharmaceuticals, Inc.
$294
Supernus Pharmaceuticals, Inc.
$292
Allergan Inc.
$269
SK Life Science, Inc.
$269
Neurocrine Biosciences, Inc.
$262
Alexion Pharmaceuticals, Inc.
$253
Kyowa Kirin, Inc.
$251
Boston Scientific Corporation
$241
Medtronic, Inc.
$232
Genentech USA, Inc.
$211
Avanir Pharmaceuticals, Inc.
$205
Lilly USA, LLC
$203
HARMONY BIOSCIENCES LLC
$184
Amgen Inc.
$175
E.R. Squibb & Sons, L.L.C.
$146
PFIZER INC.
$143
Janssen Pharmaceuticals, Inc
$139
Sunovion Pharmaceuticals Inc.
$129
Ipsen Biopharmaceuticals, Inc
$126
JAZZ PHARMACEUTICALS INC.
$112
Harmony Biosciences LLC
$105
Celgene Corporation
$97
Biohaven Pharmaceutical Holding Company Ltd.
$89
Upsher-Smith Laboratories LLC
$83
Eisai Inc.
$80
InSightec,Inc
$74
Impax Laboratories, Inc.
$68
CSL Behring
$65
PORTOLA PHARMACEUTICALS, INC.
$61
GE HEALTHCARE
$59
Merz Pharmaceuticals, LLC
$55
Merz North America, Inc.
$54
Bayer HealthCare Pharmaceuticals Inc.
$53
Egalet US Inc
$50
AbbVie, Inc.
$47
BOSTON SCIENTIFIC CORPORATION
$46
Promius Pharma LLC
$46
Vertical Pharmaceuticals, LLC
$46
Jazz Pharmaceuticals Inc.
$46
Mallinckrodt LLC
$45
Avion Pharmaceuticals
$44
Biohaven Pharmaceuticals, Inc.
$41
Arbor Pharmaceuticals, Inc.
$41
ARBOR PHARMACEUTICALS, INC.
$39
Nevro Corp.
$33
ARGENX US, INC.
$32
ASSERTIO THERAPEUTICS, Inc.
$29
Assertio Therapeutics, Inc.
$29
TG THERAPEUTICS, INC.
$24
CATALYST PHARMACEUTICALS, INC.
$23
Banner Life Sciences, LLC
$21
Fujirebio Diagnostics, Incorporated
$21
Otsuka America Pharmaceutical, Inc.
$21
GE HealthCare
$20
Bausch Health US, LLC
$20
Grifols USA, LLC
$17
GRT US Holding, Inc.
$17
Azurity Pharmaceuticals, Inc.
$17
Corium, LLC
$16
Sumitomo Pharma America, Inc.
$16
REVANCE THERAPEUTICS, INC.
$15
Mylan Pharmaceuticals Inc.
$15
Mitsubishi Tanabe Pharma America, Inc.
$15
UPSHER-SMITH LABORATORIES LLC
$12
Piramal Imaging Limited
$8
Top 3 companies account for 68.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ACTIVA PC · ADUHELM · AGAMREE · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BEVYXXA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COPAXONE · Cambia · DAXI · DUOPA · DYSPORT · Deep Brain Stimulation · Dhivy · Duopa · Dysport · EMGALITY · EPIDIOLEX · Exablate · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · General - DBS · Glatiramer Acetate · Gralise · HORIZANT · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KYNMOBI · LEMTRADA · LUMIZYME · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Neuromodulation Dspsbls and Accs · Nourianz · OCREVUS · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OSMOLEX ER · OXTELLAR XR · Ocrevus · PAXLOVID · PERCEPT PC BRAINSENSE · POMPE - DISEASE · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RECLAIM · RELEXXII · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYNCHROMED · Senza Spinal Cord Stimulation System · Soliris · TOSYMRA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VUMERITY · VYALEV · VYEPTI · VYVGART HYTRULO · Vercise · Vimpat · WAKIX · WATCHMAN · Wakix · XCOPRI · XEOMIN · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZIPSOR · Zembrace · Zilbrysq · Zinbryta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
532
County median income
$111,521
Nearest hospital to ZIP centroid (approximate)
HOLY REDEEMER HOSPITAL AND MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kubersky is a mixed practice specialist, with above-average Medicare volume (top 4% in PA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kubersky experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Kubersky performed 9,000 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kubersky receive payments from pharmaceutical companies?
Yes. Dr. Kubersky received a total of $61,224 from 82 companies across 823 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kubersky's costs compare to other neurologists in Meadowbrook?
Dr. Kubersky's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kubersky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Meadowbrook
Browse neurologists in Meadowbrook ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in PA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in PA
Which PA neurologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
US WorldMeds, LLC Payments to Doctors
See all physicians who received payments from US WorldMeds, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology